Connor, Clark & Lunn Investment Management (CC&L)
VIRX

Connor, Clark & Lunn Investment Management (CC&L)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio VIRX Stock Details VIRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-170
Closed -$87K – 672
2015
Q1 		$87K Buy
+170
New +$87K ﹤0.01% 538